1 / 4

DATA Appendix

The Impact of Systems Improvements: A Progress Review of Healthcare-Associated Infections & Blood Disorders and Blood Safety Appendix Slides. DATA Appendix. Healthcare-Associated Infections Objective Status.  HAI-1 Central line-associated bloodstream infections

cuyler
Download Presentation

DATA Appendix

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. The Impact of Systems Improvements: A Progress Review of Healthcare-Associated Infections & Blood Disorders and Blood SafetyAppendix Slides

  2. DATA Appendix

  3. Healthcare-Associated Infections Objective Status  HAI-1 Central line-associated bloodstream infections  HAI-2 Invasive healthcare-associated methicillin-resistant Staphylococcus aureusinfections Improving

  4. Blood Disorders and Blood Safety Objective Status Little or no change Baseline only Developmental  BDBS-1 Vaccinations for persons w/ hemoglobinopathies  BDBS-2 Referral for hemoglobinopathies  BDBS-3 Care in medical home for persons w/ hemoglobinopathies  BDBS-4 Early screening for complications of hemoglobinopathies  BDBS-5 Disease modifying therapies for persons w/ hemoglobinopathies  BDBS-6 Penicillin prophylaxis for children with sickle cell disease  BDBS-7 Hospitalizations due to complications in children w/ sickle cell disease  BDBS-8 High school completion among adults w/ hemoglobinopathies  BDBS-9 CBOs that provide outreach and awareness campaigns  BDBS-10 Awareness of hemoglobinopathies carrier status  BDBS-11 Vaccinations for persons w/ bleeding disorders  BDBS-12 Venous thromboembolism  BDBS-13.1-13.2 VTE among adult medical and surgical patients  BDBS-14 Provider referral for women w/ inherited bleeding disorders  BDBS-15 Timely diagnosis of VWD among women  BDBS-16 Reduced joint mobility due to joint bleeding among persons w/ hemophilia  BDBS-17 Blood donation  BDBS-18.1-18.4 Adverse events from blood and blood products.  BDBS-19.1-19.3 Blood product shortage

More Related